David Windley
Stock Analyst at Jefferies
(4.73)
# 721
Out of 5,096 analysts
808
Total ratings
59%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterated: Buy | $624 → $420 | $414.50 | +1.33% | 70 | Sep 30, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $225 → $340 | $359.41 | -5.40% | 76 | Sep 28, 2026 | |
| OSCR Oscar Health | Reiterated: Hold | $16 → $31 | $30.37 | +2.07% | 8 | Sep 17, 2026 | |
| MEDP Medpace Holdings | Reiterated: Hold | $515 → $560 | $652.01 | -14.11% | 36 | Sep 14, 2026 | |
| CI The Cigna Group | Downgraded: Hold | $330 → $307 | $298.23 | +2.94% | 65 | Aug 3, 2026 | |
| ELV Elevance Health | Reiterated: Buy | $391 → $450 | $420.07 | +7.13% | 78 | Jul 16, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $211.36 | -8.69% | 74 | Jun 25, 2026 | |
| CNC Centene | Reiterated: Hold | $43 → $39 | $68.45 | -43.02% | 88 | Apr 20, 2026 | |
| MOH Molina Healthcare | Reiterated: Hold | $160 → $139 | $204.78 | -32.12% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $340 → $373 | $406.97 | -8.35% | 73 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $18 | $19.38 | -9.70% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $295 | $412.62 | -28.51% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $255 | $267.33 | -4.61% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $18.15 | +7.44% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $9.5 | $21.29 | n/a | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.75 → $3 | $0.357 | n/a | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $263 | $227.12 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $335 | $312.96 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $15 | $11.02 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $177 → $190 | $49.30 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 → $248 | $8.51 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $5.00 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $4.30 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $0.2542 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $321.67 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $0.4921 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $200.62 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $45.34 | n/a | 1 | Aug 27, 2009 |
Humana
Sep 30, 2026
Reiterated: Buy
Price Target: $624 → $420
Current: $414.50
Upside: +1.33%
Charles River Laboratories International
Sep 28, 2026
Reiterated: Buy
Price Target: $225 → $340
Current: $359.41
Upside: -5.40%
Oscar Health
Sep 17, 2026
Reiterated: Hold
Price Target: $16 → $31
Current: $30.37
Upside: +2.07%
Medpace Holdings
Sep 14, 2026
Reiterated: Hold
Price Target: $515 → $560
Current: $652.01
Upside: -14.11%
The Cigna Group
Aug 3, 2026
Downgraded: Hold
Price Target: $330 → $307
Current: $298.23
Upside: +2.94%
Elevance Health
Jul 16, 2026
Reiterated: Buy
Price Target: $391 → $450
Current: $420.07
Upside: +7.13%
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $211.36
Upside: -8.69%
Centene
Apr 20, 2026
Reiterated: Hold
Price Target: $43 → $39
Current: $68.45
Upside: -43.02%
Molina Healthcare
Apr 20, 2026
Reiterated: Hold
Price Target: $160 → $139
Current: $204.78
Upside: -32.12%
UnitedHealth Group
Apr 20, 2026
Reiterated: Buy
Price Target: $340 → $373
Current: $406.97
Upside: -8.35%
Feb 10, 2026
Reiterated: Hold
Price Target: $21 → $18
Current: $19.38
Upside: -9.70%
Feb 10, 2026
Reiterated: Buy
Price Target: $365 → $295
Current: $412.62
Upside: -28.51%
Feb 6, 2026
Reiterated: Buy
Price Target: $225 → $255
Current: $267.33
Upside: -4.61%
Nov 20, 2025
Reiterated: Buy
Price Target: $16 → $20
Current: $18.15
Upside: +7.44%
Sep 8, 2025
Reiterated: Hold
Price Target: $21 → $9.5
Current: $21.29
Upside: n/a
Aug 25, 2025
Reiterated: Hold
Price Target: $2.75 → $3
Current: $0.357
Upside: n/a
Jun 4, 2025
Reiterated: Hold
Price Target: $263
Current: $227.12
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $280 → $335
Current: $312.96
Upside: n/a
Apr 21, 2025
Reiterated: Hold
Price Target: $16 → $15
Current: $11.02
Upside: n/a
Apr 26, 2021
Reiterated: Buy
Price Target: $177 → $190
Current: $49.30
Upside: n/a
Feb 25, 2021
Reiterated: Hold
Price Target: $200 → $248
Current: $8.51
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $5.00
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $4.30
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $0.2542
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $321.67
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $0.4921
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $200.62
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $45.34
Upside: n/a